Chlorhexidine Gluconate Patent Expiration

Chlorhexidine Gluconate is a drug owned by Sage Products Inc. It is protected by 5 US drug patents filed in 2013. Out of these, 3 drug patents are active and 2 have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Oct 02, 2027. Details of Chlorhexidine Gluconate's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7935093 Disinfectant delivery system and method of providing alcohol-free disinfection
Oct, 2027

(2 years from now)

Active
US7427574 Non-woven wash cloth
Apr, 2026

(1 year, 4 months from now)

Active
US7717889 Disinfectant delivery system and method of providing alcohol free disinfection
Feb, 2025

(2 months from now)

Active
US7066916 Disinfectant delivery system, and method of providing alcohol-free disinfection
Feb, 2024

(10 months ago)

Expired
US7595021 Method of providing alcohol-free disinfection
May, 2023

(1 year, 7 months ago)

Expired


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Chlorhexidine Gluconate's patents.

Given below is the list of recent legal activities going on the following patents of Chlorhexidine Gluconate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 19 Oct, 2022 US7935093
Payment of Maintenance Fee, 12th Year, Large Entity 03 Nov, 2021 US7717889
Payment of Maintenance Fee, 12th Year, Large Entity 17 Mar, 2021 US7595021
Payment of Maintenance Fee, 12th Year, Large Entity 17 Mar, 2020 US7427574
Payment of Maintenance Fee, 8th Year, Large Entity 18 Oct, 2018 US7935093
Payment of Maintenance Fee, 12th Year, Large Entity 21 Dec, 2017 US7066916
Payment of Maintenance Fee, 8th Year, Large Entity 07 Nov, 2017 US7717889
Change in Power of Attorney (May Include Associate POA) 26 Jun, 2017 US7595021
Email Notification 26 Jun, 2017 US7595021
Correspondence Address Change 23 Jun, 2017 US7595021

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Chlorhexidine Gluconate is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Chlorhexidine Gluconate's family patents as well as insights into ongoing legal events on those patents.

Chlorhexidine Gluconate's Family Patents

Chlorhexidine Gluconate has patent protection in a total of 2 countries. It has a significant patent presence in the US with 72.7% of its patents being US patents. Click below to unlock the full patent family tree for Chlorhexidine Gluconate.

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Chlorhexidine Gluconate's generic launch date based on the expiry of its last outstanding patent is estimated to be Oct 02, 2027 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Chlorhexidine Gluconate Generic API suppliers:

Chlorhexidine Gluconate is the generic name for the brand Chlorhexidine Gluconate. 13 different companies have already filed for the generic of Chlorhexidine Gluconate, with J And J having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Chlorhexidine Gluconate's generic

Alternative Brands for Chlorhexidine Gluconate

Chlorhexidine Gluconate which is used for disinfection and preparation of patient skin to reduce bacteria before invasive medical procedures., has several other brand drugs in the same treatment category and using the same active ingredient (Chlorhexidine Gluconate). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Drug Owner Drug Name Treatment Area
3m Health Care
Soluprep S

(uses Chlorhexidine Gluconate)

Used for reducing bacteria on the skin prior to surgery to prevent potential infections.

Apart from drugs working in same treatment category, there are also some brand drugs where treatment area is different, but the active ingredient used is same i.e. Chlorhexidine Gluconate. Given below is the list of those drugs and companies owning them.



Apart from brand drugs containing the same ingredient, some generics have also been filed for Chlorhexidine Gluconate, Chlorhexidine Gluconate's active ingredient. Check the complete list of approved generic manufacturers for Chlorhexidine Gluconate





About Chlorhexidine Gluconate

Chlorhexidine Gluconate is a drug owned by Sage Products Inc. It is used for disinfection and preparation of patient skin to reduce bacteria before invasive medical procedures. Chlorhexidine Gluconate uses Chlorhexidine Gluconate as an active ingredient. Chlorhexidine Gluconate was launched by Sage Prods in 2005.

Approval Date:

Chlorhexidine Gluconate was approved by FDA for market use on 25 April, 2005.

Active Ingredient:

Chlorhexidine Gluconate uses Chlorhexidine Gluconate as the active ingredient. Check out other Drugs and Companies using Chlorhexidine Gluconate ingredient

Treatment:

Chlorhexidine Gluconate is used for disinfection and preparation of patient skin to reduce bacteria before invasive medical procedures.

Dosage:

Chlorhexidine Gluconate is available in cloth form for topical use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
2% CLOTH Over the counter TOPICAL